762
Views
12
CrossRef citations to date
0
Altmetric
Basic science

Cholesterol- and lanolin-rich diets may protect against steroid-induced osteonecrosis in rabbits

, , , , , & show all
Pages 593-597 | Received 03 May 2013, Accepted 02 Sep 2013, Published online: 31 Oct 2013

  • Abe I, Rohmer M, Prestwich GD. Enzymatic cyclization of squalene and oxidosqualene to sterols and triterpenes. Chem Rev 1993; 93: 2189-206.
  • Clark EW. A brief history of lanolin. Pharm Hist (Lond) 1980; 10: 5-6.
  • Corey EJ, Russey WE, Ortiz de Montellano PR. 2, 3-oxidosqualene, an intermediate in the biological synthesis of sterols from squalene. J Am Chem Soc 1966; 88: 4750-1.
  • Fahy E, Subramaniam S, Brown HA, et al.. A comprehensive classification system for lipids. J Lipid Res 2005; 46: 839-61.
  • Goldberg AC, Hopkins PN, Toth PP, et al.. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011; 5: 133-40.
  • Ikemura S, Yamamoto T, Motomura G, et al.. Lipid metabolism abnormalities in alcohol-treated rabbits: a morphometric and haematologic study comparing high and low alcohol doses. Int J Exp Path 2011; 92: 290-5.
  • Kang P, Pei F, Shen B, Yang J, Cheng J. Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits. Joint Bone Spine 2008; 75: 696-701.
  • Klop B, Wouter Jukema J, Rabelink TJ, Castro Cabezas M. A physician’s guide for the management of hypertriglyceridemia: the etiology of hypertriglyceridemia determines treatment strategy. Panminerva Med 2012; 54: 91-103.
  • Miyanishi K, Yamamoto T, Irisa T, et al.. A high low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a potential risk factor for corticosteroid-induced osteonecrosis in rabbits. Rheumatology (Oxford) 2001; 40: 196-201.
  • Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg (Am) 1995; 77: 459-74.
  • Monte MJ, Fernandez-Tagarro M, Macias RI, Jimenez F, Gonzalez-San Martin F, Marin JJ. Changes in the expression of genes related to bile acid synthesis and transport by the rat liver during hepatocarcinogenesis. Clin Sci 2005; 109: 199-207.
  • Motomura G, Yamamoto T, Miyanishi K, Jingushi S, Iwamoto Y. Combined effects of an anticoagulant and a lipid-lowering lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Arthritis Rheum 2004; 50: 3387-91.
  • Motomura G, Yamamoto T, Miyanishi K, Kondo K, Hirota Y, Iwamoto Y. Risk factors for developing osteonecrosis after prophylaxis in steroid-treated rabbits. J Rheumatol 2008; 35: 2391-4.
  • Nixon M, Upreti R, Andrew R. 5α-Reduced glucocorticoids: a story of natural selection. J Endocrinol 2012; 212: 111-27.
  • Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546-51.
  • Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop 2001; (386): 173-8.
  • Wang GJ, Moga DB, Richemer WG, Sweet DE, Reger SI, Thompson RC. Cortisone induced bone changes and its response to lipid clearing agents. Clin Orthop 1978; (130): 81-5.
  • Yamaguchi R, Yamamoto T, Motomura G, et al.. Effects of an anti-platelet drug on the prevention of steroid-induced osteonecrosis in rabbits. Rheumatology (Oxford) 2012; 51: 789-93.
  • Yamamoto T, Irisa T, Sugioka Y, Sueishi K. Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits. Arthritis Rheum 1997; 40: 2055-64.